Burden of Disease and Productivity Loss in the European Economic Area in Patients Affected by Fibrosing Interstitial Lung Disease
ConclusionThe impact of non-IPF PPF and SSc-ILD on society is definitely non-negligible. Actions to reduce the burden on our societies are highly needed.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Disability | Drugs & Pharmacology | Healthcare Costs | Interstitial Lung Disease | Scleroderma | Study